PL3468535T3 - Solubilizator resweratrolu do zastosowań farmaceutycznych - Google Patents

Solubilizator resweratrolu do zastosowań farmaceutycznych

Info

Publication number
PL3468535T3
PL3468535T3 PL17702347T PL17702347T PL3468535T3 PL 3468535 T3 PL3468535 T3 PL 3468535T3 PL 17702347 T PL17702347 T PL 17702347T PL 17702347 T PL17702347 T PL 17702347T PL 3468535 T3 PL3468535 T3 PL 3468535T3
Authority
PL
Poland
Prior art keywords
resveratrol
solubilizer
pharmaceutical applications
pharmaceutical
applications
Prior art date
Application number
PL17702347T
Other languages
English (en)
Inventor
Dariush Behnam
Marshall A. Hayward
Original Assignee
Aquanova Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aquanova Ag filed Critical Aquanova Ag
Publication of PL3468535T3 publication Critical patent/PL3468535T3/pl

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4816—Wall or shell material
    • A61K9/4825—Proteins, e.g. gelatin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/48—Drugs for disorders of the endocrine system of the pancreatic hormones

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Molecular Biology (AREA)
  • Dispersion Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biophysics (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Biochemistry (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Psychology (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
PL17702347T 2016-06-14 2017-01-26 Solubilizator resweratrolu do zastosowań farmaceutycznych PL3468535T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP2016063579 2016-06-14
PCT/EP2017/051659 WO2017215791A1 (en) 2016-06-14 2017-01-26 Resveratrol solubilisation product for pharmaceutical purposes
EP17702347.0A EP3468535B1 (en) 2016-06-14 2017-01-26 Resveratrol solubilisation product for pharmaceutical purposes

Publications (1)

Publication Number Publication Date
PL3468535T3 true PL3468535T3 (pl) 2020-09-07

Family

ID=57944408

Family Applications (1)

Application Number Title Priority Date Filing Date
PL17702347T PL3468535T3 (pl) 2016-06-14 2017-01-26 Solubilizator resweratrolu do zastosowań farmaceutycznych

Country Status (9)

Country Link
US (1) US10780056B2 (pl)
EP (1) EP3468535B1 (pl)
JP (1) JP6907243B2 (pl)
CN (1) CN109562066B (pl)
DK (1) DK3468535T3 (pl)
ES (1) ES2798403T3 (pl)
HU (1) HUE049304T2 (pl)
PL (1) PL3468535T3 (pl)
WO (1) WO2017215791A1 (pl)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR102228135B1 (ko) * 2018-07-19 2021-03-16 조선대학교산학협력단 레스베라트롤을 포함하는 고형 제제 형태의 약학 조성물 및 레스베라트롤의 가용화 방법
WO2023023323A1 (en) * 2021-08-20 2023-02-23 Jupiter Neurosciences, Inc. Resveratrol pharmaceutical compositions and methods of use thereof
CN113812552B (zh) * 2021-09-01 2023-12-26 江南大学 一种全营养固体饮料
EP4678167A1 (en) * 2024-07-04 2026-01-14 Laboratorio della Farmacia S.p.A. Solid oral composition with gradual enteric release for lipophilic active ingredients
US12599569B1 (en) * 2024-12-30 2026-04-14 King Saud University Encapsulated resveratrol (RSV) nanoparticles

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7582674B2 (en) * 2003-05-27 2009-09-01 Dsm Ip Assets B.V. Nutraceutical compositions and use thereof
US20060270732A1 (en) * 2005-05-26 2006-11-30 Suracell, Inc. Antioxidant supplement compostion and method of use
CN101874763A (zh) * 2009-04-29 2010-11-03 上海家化联合股份有限公司 一种白藜芦醇柔性脂质体及其制备方法
CA2863544C (en) * 2012-02-10 2019-03-26 Virun, Inc. Beverage compositions containing non-polar compounds
KR20140071913A (ko) * 2012-12-04 2014-06-12 삼성정밀화학 주식회사 식품 조성물 및 이를 포함하는 연질 캡슐
DE202012012130U1 (de) * 2012-12-19 2014-03-21 Aquanova Ag Curcuminsolubilisat
US9861611B2 (en) * 2014-09-18 2018-01-09 Virun, Inc. Formulations of water-soluble derivatives of vitamin E and soft gel compositions, concentrates and powders containing same

Also Published As

Publication number Publication date
JP6907243B2 (ja) 2021-07-21
WO2017215791A1 (en) 2017-12-21
CN109562066A (zh) 2019-04-02
JP2019518047A (ja) 2019-06-27
CA3026810A1 (en) 2017-12-21
HUE049304T2 (hu) 2020-09-28
CN109562066B (zh) 2021-08-10
EP3468535A1 (en) 2019-04-17
EP3468535B1 (en) 2020-05-27
US20190307700A1 (en) 2019-10-10
US10780056B2 (en) 2020-09-22
ES2798403T3 (es) 2020-12-11
DK3468535T3 (da) 2020-07-06

Similar Documents

Publication Publication Date Title
IL282304A (en) Topical pharmaceutical compositions
LT3485309T (lt) Interferometrinė sklaidos mikroskopija
SI3529248T1 (sl) Farmacevtske spojine
EP3513809A4 (en) MEDICAL COMPOSITION
EP3415959A4 (en) ANTI REFLEX COATING
DK3105049T3 (da) Videresalgsmodvirkende farmaceutisk emballeringsfilm
DOS2016000088S (es) Recipientes para dispositivos medicos
PL4070788T3 (pl) Formulacje farmaceutyczne
EP3454899C0 (en) PHARMACEUTICAL COMPOSITION
DK3310414T3 (da) Lægemiddeladministrationsanordning
DK3532029T3 (da) Flydende farmaceutisk sammensætning
DK3529240T3 (da) Farmaceutiske forbindelser
EP3547972A4 (en) THERMOPLASTIC ORTHOPEDIC DEVICES
SI3457851T1 (sl) Derivati sobetiroma
EP3424940A4 (en) Radiolabeled drug
EP3378902A4 (en) ANTI REFLEX FILM
EP3507315A4 (en) MODIFIED POLYETHYLENE
DK3463345T3 (da) Farmaceutiske kombinationer
EP3542773A4 (en) DRUG PACKAGING DEVICE
EP3413101A4 (en) ANTI REFLECTION FILM
EP3437644A4 (en) MEDICINE
MA44987A (fr) Formulations de médicaments améliorées
DK3508519T3 (da) Film
EP3527216A4 (en) MEDICINE
DK3280447T3 (da) Farmaceutiske formuleringer